Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 9Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 4Carcinoma, Intraductal, Noninfiltrating 3Uterine Cervical Neoplasms 2Endometrial Neoplasms 2Eccrine Porocarcinoma 2Vulvar Neoplasms 1Sentinel Lymph Node Biopsy (SLNB) 1Sentinel Lymph Node 1Sarcoidosis, Pulmonary 1Sarcoidosis 1Neoplasm Micrometastasis 1Melanoma 1Lymphoma 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Carcinoma, Merkel Cell 1Breast Carcinoma In Situ 1Anus Neoplasms 1

Interventions

Blood Specimen Collection 14Nivolumab 13Ipilimumab 12pembrolizumab 11trametinib 9Surveys and Questionnaires 9Gene Expression Profiling 9dabrafenib 8Biopsy 6Specimen Handling 5Immunotherapy 5Immunohistochemistry 5Amplified Fragment Length Polymorphism Analysis 4encorafenib 3binimetinib 3atezolizumab 3Restraint, Physical 3Quality of Life 3Polymerase Chain Reaction 3Introns 3Flow Cytometry 3Drug Therapy 3Data Collection 3tremelimumab 2pimonidazole 2cobimetinib 2aldesleukin 2Watchful Waiting 2Vemurafenib 2Therapeutics 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Melanoma × Sentinel Lymph Node Biopsy × Clear all
NCT00897481 2013-08-12

Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy

National Cancer Institute (NCI)

Unknown
1,000 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡